Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRY
3301
DELISTED
Berry Corp
BRY
| $387K | ﹤0.01% |
70,300
+21,182
| +43% | +$104K |
|
|
RNET
3302
DELISTED
RigNet, Inc.
RNET
| $387K | ﹤0.01% |
+44,359
| New | +$389K |
|
3303
AnaptysBio
ANAB
$1.58B
| $386K | ﹤0.01% |
17,899
+10,520
| +143% | +$266K |
|
3304
AXT Inc
AXTI
$3.95B
| $385K | ﹤0.01% |
33,012
+20,265
| +159% | +$243K |
|
3305
Geron
GERN
$828M
| $385K | ﹤0.01% |
243,729
+146,582
| +151% | +$262K |
|
3306
Omega Flex
OFLX
$297M
| $385K | ﹤0.01% |
2,433
+1,496
| +160% | +$235K |
|
3307
Consolidated Water Co
CWCO
$467M
| $383K | ﹤0.01% |
28,506
+4,603
| +19% | +$61.4K |
|
|
FPI
3308
Farmland Partners
FPI
$408M
| $382K | ﹤0.01% |
34,151
+15,967
| +88% | +$182K |
|
3309
Hurco Companies Inc
HURC
$135M
| $381K | ﹤0.01% |
10,780
+3,023
| +39% | +$97.8K |
|
3310
NextCure
NXTC
$16.9M
| $381K | ﹤0.01% |
3,173
-456
| -13% | -$66K |
|
|
MYOV
3311
DELISTED
Myovant Sciences Ltd.
MYOV
| $381K | ﹤0.01% |
18,536
-27,964
| -60% | -$637K |
|
3312
First Bank
FRBA
$464M
| $380K | ﹤0.01% |
31,237
+1,629
| +6% | +$17.6K |
|
3313
ACNB Corp
ACNB
$656M
| $379K | ﹤0.01% |
12,927
+3,724
| +40% | +$104K |
|
3314
Schwab US Dividend Equity ETF
SCHD
$103B
| $379K | ﹤0.01% |
+15,594
| New | +$355K |
|
3315
Navigator Holdings
NVGS
$1.38B
| $378K | ﹤0.01% |
42,567
+17,151
| +67% | +$174K |
|
3316
Powell Industries
POWL
$7.6B
| $378K | ﹤0.01% |
33,444
-6,273
| -16% | -$66.1K |
|
3317
Waterstone Financial
WSBF
$370M
| $378K | ﹤0.01% |
18,529
+11,510
| +164% | +$228K |
|
3318
Tilly's
TLYS
$116M
| $377K | ﹤0.01% |
33,303
-4,917
| -13% | -$52.6K |
|
|
XONE
3319
DELISTED
The ExOne Company
XONE
| $377K | ﹤0.01% |
12,022
+7,794
| +184% | +$245K |
|
3320
Crinetics Pharmaceuticals
CRNX
$8.84B
| $375K | ﹤0.01% |
24,582
+13,674
| +125% | +$212K |
|
3321
Gencor Industries
GENC
$209M
| $375K | ﹤0.01% |
28,013
+5,179
| +23% | +$69.5K |
|
3322
IDT Corp
IDT
$1.64B
| $375K | ﹤0.01% |
16,571
+10,173
| +159% | +$182K |
|
|
MCF
3323
DELISTED
Contango Oil & Gas Co.
MCF
| $374K | ﹤0.01% |
95,911
+66,365
| +225% | +$255K |
|
|
SAL
3324
DELISTED
Salisbury Bancorp, Inc.
SAL
| $373K | ﹤0.01% |
16,742
+1,344
| +9% | +$27.6K |
|
3325
CALL
CF Industries
CF
$19.2B
| $372K | ﹤0.01% |
8,200
-11,100
| -58% | -$501K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.